The store-operated Ca²⁺ release-activated Ca²⁺ (CRAC) channel is activated by diminished luminal Ca²⁺ levels in the endoplasmic reticulum and sarcoplasmic reticulum (SR), and constitutes one of the major Ca²⁺ entry pathways in various tissues. Tubular aggregates (TAs) are abnormal structures in the skeletal muscle, and although their mechanism of formation has not been clarified, altered Ca²⁺ homeostasis related to a disordered SR is suggested to be one of the main contributing factors. TA myopathy is a hereditary muscle disorder that is pathologically characterized by the presence of TAs. Recently, dominant mutations in the STIM1 gene, encoding a Ca²⁺ sensor that controls CRAC channels, have been identified to cause tubular aggregate myopathy (TAM). Here, we identified heterozygous missense mutations in the ORAI1 gene, encoding the CRAC channel itself, in three families affected by dominantly inherited TAM with hypocalcemia. Skeletal myotubes from an affected individual and HEK293 cells expressing mutated ORAI1 proteins displayed spontaneous extracellular Ca²⁺ entry into cells without diminishment of luminal Ca²⁺ or the association with STIM1. Our results indicate that STIM1-independent activation of CRAC channels induced by dominant mutations in ORAI1 cause altered Ca²⁺ homeostasis, resulting in TAM with hypocalcemia.